Reviva Pharmaceuticals Holdings, Inc. Stock Forecast
Reviva Pharmaceuticals Holdings, Inc. stock price ended at $2.98 on Thursday, after losing 1.32%.
(Updated on Apr 25, 2024)
The Reviva Pharmaceuticals Holdings, Inc. stock price fell by -1.32% on the last day (Thursday, 25th Apr 2024) from $3.02 to $2.98. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 6.90% from a day low at $2.90 to a day high of $3.10. The price has fallen in 8 of the last 10 days and is down by -21.37% for this period. Volume has increased on the last day by 29 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 107 thousand shares were bought and sold for approximately $319.27 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -23.23% during the next 3 months and, with a 90% probability hold a price between $1.78 and $2.90 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
RVPH Signals & Forecast
There are few to no technical positive signals at the moment. The Reviva Pharmaceuticals Holdings, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.06 and $3.32. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -23.59%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Reviva Pharmaceuticals Holdings, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Reviva Pharmaceuticals Holdings, Inc. stock
Reviva Pharmaceuticals Holdings, Inc. finds support from accumulated volume at $2.89 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.200 between high and low, or 6.90%. For the last week, the stock has had daily average volatility of 6.40%.
Reviva Pharmaceuticals Holdings, Inc. is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (RVPH) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Reviva Pharmaceuticals Holdings, Inc. to open at $2.99, and during the day (based on 14 day Average True Range), to move between $2.72 and $3.24, which gives a possible trading interval of +/-$0.260 (+/-8.72%) up or down from last closing price. If Reviva Pharmaceuticals Holdings, Inc. takes out the full calculated possible swing range there will be an estimated 17.45% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.89 (3.02%) than the resistance at $3.38 (13.42%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Reviva Pharmaceuticals Holdings, Inc. stock A Buy?
Reviva Pharmaceuticals Holdings, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -3.463 Sell Candidate Unchanged
Predicted Opening Price for Reviva Pharmaceuticals Holdings, Inc. of Friday, April 26, 2024
| Fair opening price April 26, 2024 | Current price |
|---|---|
| $2.99 ( 0.447%) | $2.98 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for RVPH
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.19 | 7.16 % | |
| R2 | 3.12 | 4.60 % | ||
| R1 | 3.07 | 3.01 % | ||
| Current price: | 2.98 | |||
| Support | S1 | 2.92 | -2.12 % | |
| S2 | 2.87 | -3.70 % | ||
| S3 | 2.79 | -6.26 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.62 | 21.48 % | |
| R2 | 3.48 | 16.78 % | ||
| R1 | 3.38 | 13.42 % | ||
| Current price | 2.98 | |||
| Support | S1 | 2.89 | -3.02% | |
| S2 | 2.84 | -4.70% | ||
| S3 | 2.80 | -6.04% |
FAQ
Click here for our free guide on how to buy Reviva Pharmaceuticals Holdings, Inc. Stock.
